The previously announced acquisition of the pharmaceutical business of 3M (NYSE: MMM) in the United States, Puerto Rico, Canada and Latin America by Graceway Pharmaceuticals, LLC (a portfolio company of GTCR Golder Rauner, LLC, 14092026) have already been completed.
Among other assets, the acquisition included all of 3M’s branded pharmaceutical products and as part of the transaction, both companies have sealed manufacturing agreements for the products as well as a technology access and development agreement. The products acquired included the following:
- Aldara® (imiquimod) Cream 5% indicated for the treatment of external genital warts, actinic keratosis, and superficial basal cell carcinoma in certain circumstances.
- MaxAir™ (pirbuterol acetate inhalation aerosol) Autohaler™ indicated for the prevention and reversal of asthmatic attacks.
- plus: related new drug applications, trademarks, copyrights, patents, licenses to certain patents associated with potential new formulations of the products, and other related intellectual property.
Comment Preview